Annual Drug Patent Expirations for ZURZUVAE
Zurzuvae is a drug marketed by Biogen Inc and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
This drug has ninety-two patent family members in thirty-six countries.
The generic ingredient in ZURZUVAE is zuranolone. One supplier is listed for this compound. Additional details are available on the zuranolone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
